Ramon Mohanlal
Director/Board Member at Seed Therapeutics, Inc.
Profile
Ramon W.
Mohanlal is currently a Director at Seed Therapeutics, Inc. Prior to his current position, he served as Director, Chief Medical Officer, and Executive VP-R&D at BeyondSpring, Inc. from 2015 to 2023.
Ramon also held positions as Chief Medical Officer at Vertex Pharmaceuticals, Inc., Clinical Head-Established Oncology Products at Novartis AG, and Chief Executive & Medical Officer at BioPremiere, Inc. He was also a Principal at Glaxo Wellcome Plc and Pharmacia Corp.
Ramon holds a doctorate from the University of Leiden and an MBA from American InterContinental University System, Inc.
Ramon Mohanlal active positions
| Companies | Position | Start |
|---|---|---|
| Seed Therapeutics, Inc. | Director/Board Member | 2020-07-31 |
Former positions of Ramon Mohanlal
| Companies | Position | End |
|---|---|---|
| BEYONDSPRING INC. | Chief Tech/Sci/R&D Officer | 2023-02-15 |
| NOVARTIS AG | Corporate Officer/Principal | 2015-06-30 |
BioPremiere, Inc.
 BioPremiere, Inc. Pharmaceuticals: MajorHealth Technology BioPremiere Inc. operates as a biopharmaceutical company. The company is headquartered in Boston, MA. | Chief Executive Officer | 2008-12-31 |
| INTERLEUKIN GENETICS, INC | Chief Tech/Sci/R&D Officer | 2007-08-16 |
| Glaxo Wellcome Plc | Corporate Officer/Principal | - |
Training of Ramon Mohanlal
| American InterContinental University System, Inc. | Masters Business Admin |
| University of Leiden | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| NOVARTIS AG | Health Technology |
| BEYONDSPRING INC. | Health Technology |
| Private companies | 5 |
|---|---|
| Glaxo Wellcome Plc | Health Technology |
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
BioPremiere, Inc.
BioPremiere, Inc. Pharmaceuticals: MajorHealth Technology BioPremiere Inc. operates as a biopharmaceutical company. The company is headquartered in Boston, MA. | Health Technology |
| Seed Therapeutics, Inc. |
- Stock Market
- Insiders
- Ramon Mohanlal
